DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹1,022 Cr | ₹778 Cr | ₹212 Cr | ₹470 Cr | ₹711 Cr |
What is the latest Capital Work in Progress ratio of DIVIS LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹778 Cr |
| Mar2023 | ₹212 Cr |
| Mar2022 | ₹470 Cr |
| Mar2021 | ₹711 Cr |
How is Capital Work in Progress of DIVIS LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,022 Cr | 31.36 | |
| Mar2024 | ₹778 Cr | 266.98 | |
| Mar2023 | ₹212 Cr | -54.89 | |
| Mar2022 | ₹470 Cr | -33.87 | |
| Mar2021 | ₹711 Cr | - | |
Compare Capital Work in Progress of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹168,771.7 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
| MANKIND PHARMA | ₹92,629.3 Cr | -0.6% | 4.7% | -19.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.6% |
0.2% |
11.6% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses